Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pulmonary Hypertension, Primary, 3”

47 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 47 results

Large-scale testing (Phase 3)Enrolling By InvitationNCT03683186
What this trial is testing

A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension

Who this might be right for
PAHPulmonary HypertensionPulmonary Arterial Hypertension+8 more
United Therapeutics 1,000
Large-scale testing (Phase 3)Ended earlyNCT05036135
What this trial is testing

AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension
Aerovate Therapeutics 202
Large-scale testing (Phase 3)WithdrawnNCT03602781
What this trial is testing

Study of PAH Subjects With LTOT Use That Have Demonstrated Improved Exercise Tolerance With the Use of Inhaled Nitric

Who this might be right for
Pulmonary Arterial Hypertension
Bellerophon Pulse Technologies
Large-scale testing (Phase 3)Active Not RecruitingNCT04691154
What this trial is testing

Evaluate the Safety and Tolerability of L606 in Subjects With PAH or PH-ILD

Who this might be right for
Pulmonary Arterial HypertensionPulmonary Hypertension Due to Lung Diseases
Liquidia Technologies, Inc. 28
Large-scale testing (Phase 3)Study completedNCT04576988
What this trial is testing

Sotatercept for the Treatment of Pulmonary Arterial Hypertension (MK-7962-003/A011-11)(STELLAR)

Who this might be right for
Pulmonary Arterial Hypertension
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 324
Large-scale testing (Phase 3)Ended earlyNCT02725372
What this trial is testing

Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH

Who this might be right for
Pulmonary Arterial Hypertension
Bellerophon Pulse Technologies 207
Testing effectiveness (Phase 2)Looking for participantsNCT04778046
What this trial is testing

Pulmonary Hypertension SOLAR

Who this might be right for
Interstitial Lung DiseaseCOPDPulmonary Arterial Hypertension
Bastiaan Driehuys 30
Large-scale testing (Phase 3)Ended earlyNCT01210443
What this trial is testing

Long-Term Open-Label, Safety Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patients

Who this might be right for
Hypertension, Pulmonary
Pfizer 2
Large-scale testing (Phase 3)Study completedNCT05934526
What this trial is testing

Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)

Who this might be right for
Pulmonary Arterial Hypertension
GB002, Inc. 390
Not applicableEnded earlyNCT04008550
What this trial is testing

Prognostic Impact of the Evolution of PAH 3 Months After TAVI (HTP-TAVI)

Who this might be right for
Aortic Valve StenosisPulmonary Hypertension
University Hospital, Rouen 101
Large-scale testing (Phase 3)Ended earlyNCT04811092
What this trial is testing

Study of Sotatercept in Newly Diagnosed Intermediate- and High-Risk PAH Participants (MK-7962-005/A011-13)

Who this might be right for
Pulmonary Arterial Hypertension
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 321
Testing effectiveness (Phase 2)Looking for participantsNCT06846554
What this trial is testing

A Trial of "APL-9796'' in Adults With Pulmonary Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Apollo Therapeutics Ltd 48
Large-scale testing (Phase 3)Ended earlyNCT00796510
What this trial is testing

Study Providing Monotherapy (Sitaxsentan) And Combination Therapy (Sitaxsentan+Sildenafil) To Subjects With Pulmonary Arterial Hypertension (PAH) To Assess Long-Term Safety

Who this might be right for
Pulmonary Arterial HypertensionPulmonary Hypertension
Pfizer 3
Large-scale testing (Phase 3)Study completedNCT03904693
What this trial is testing

Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)
Actelion 187
Large-scale testing (Phase 3)Study completedNCT01338415
What this trial is testing

FUTURE 3 Study Extension

Who this might be right for
Pulmonary Arterial Hypertension
Actelion 58
Large-scale testing (Phase 3)Ended earlyNCT04084678
What this trial is testing

Study of Ralinepag on Exercise Capacity by Cardiopulmonary Exercise Testing (CPET) in WHO Group 1 PH Subjects

Who this might be right for
Pulmonary HypertensionPulmonary Arterial Hypertension
United Therapeutics 10
Large-scale testing (Phase 3)Study completedNCT03626688
What this trial is testing

A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients

Who this might be right for
PAHPulmonary HypertensionPulmonary Arterial Hypertension+8 more
United Therapeutics 687
Large-scale testing (Phase 3)Study completedNCT01743001
What this trial is testing

Clinical Study to Evaluate the Effects of Macitentan on Exercise Capacity in Subjects With Eisenmenger Syndrome

Who this might be right for
Pulmonary Arterial Hypertension
Actelion 226
Testing effectiveness (Phase 2)Study completedNCT05224531
What this trial is testing

Effect of CS1 in Subjects With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Cereno Scientific AB 25
Large-scale testing (Phase 3)Looking for participantsNCT07481981
What this trial is testing

Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension
Insmed Incorporated 344
Next Page